HOME >> MEDICINE >> NEWS
Timing of women's labor may determine effectiveness of pain medication

WINSTON-SALEM, N.C. Natural daily body rhythms may influence the effectiveness of spinal-epidural pain medication for women in labor, according to new research from Wake Forest University Baptist Medical Center. The study found that women who had day labor got longer pain relief than women with night labor with the same amount of labor pain medicine.

"Our research shows that the time of day that the medication is delivered is important in determining its effectiveness," said Peter H. Pan, M.D., an obstetrical anesthesiologist. "In the future, doctors may consider time of day, as well as patient's weight and other factors, when determining the best dose or method of drug delivery."

The study's goal was to determine if the body's natural internal rhythms can affect the effectiveness of pain medication for laboring women. The study, reported in the current issue of Anesthesiology, involved 77 women who were in labor with their first babies and requested spinal-epidural pain medication.

The research is part of the field of chronobiology that studies biologic rhythms. These rhythms include the circadian rhythm, the 24-hour body clock, and the ultradian rhythm, shorter-than-24-hour-cycles, which determine sleeping and eating patterns and can also affect blood pressure, heart rate and body temperature. Some rhythms are controlled by sunlight and others are controlled internally.

The researchers found that women who labored between noon and 6 p.m. got an average of 27 percent longer pain relief from a single dose of the spinal-epidural medication fentanyl than women whose labor was between 8 p.m. and 2 a.m. Fentanyl is one of the commonly used drugs for labor pain relief in the United States. However, this is one of the first studies to examine whether there are chronobiological variations in its effectiveness for labor pain relief.

"The right treatment given at the wrong time can be ineffective or create a crisis of escalating
'"/>

Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
15-Sep-2005


Page: 1 2

Related medicine news :

1. Timing of radiation treatments for colon cancer may need adjusting, Jefferson researchers say
2. Timing possible treatments against Alzheimers disease
3. Timing of introduction of gluten into infants diet associated with appearance of celiac disease
4. Moderate drinking lowers womens risk of heart attack
5. Prioritizing womens health
6. Updated guidelines advise focusing on womens lifetime heart risk
7. Extra cortisol protects womens mood under stress
8. Finger length ratio may predict womens sporting prowess
9. Weight worries affect womens motivation to stay smoke-free after pregnancy
10. Target womens depression to reduce disability from chronic conditions, suggests study
11. Race and income converge to shape womens experiences with advanced breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Timing women labor may determine effectiveness pain medication

(Date:7/31/2015)... ... ... ZH Healthcare announces a new cloud based service delivering Health IT as ... Service (HITaaS) is a Healthcare dedicated cloud based service that sits over infrastructure as ... all aspects of infrastructure, security, runtime, middleware, OS, virtualization, Servers, storage, contracts, and ...
(Date:7/31/2015)... ... ... therapy for knee osteoarthritis is an important part of knee pain treatment. ... doing what they want or need to do. The patient may have trouble getting in ... exercise regime may be limited by the pain in their knee. When a patient sees ...
(Date:7/31/2015)... ... , ... New Energy Works Timberframers invites the public to join their timber ... from 9am – 12pm. Timber frame raisings are special, celebrating both craft ... the culmination of months of effort, planning, fundraising, and dreaming takes shape. , ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The Radiology ... Michael Burgess, MD, (R-Tex) presenting “What’s Next for Health Care: A View From Capitol ... and founder of the Congressional Health Caucus, Rep. Burgess has a special understanding of ...
(Date:7/31/2015)... ... ... “ Crack’em ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... can be a very messy experience, especially when cracking eggs. Cracking an egg is ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3Health News:Make Less Mess while Cooking with Crack’em 2
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... 30, 2015  Medimetriks Pharmaceuticals, Inc. announced today ... III clinical study for Ozenoxacin, a novel bactericidal ... the exclusive U.S. rights to Ozenoxacin 1% cream.  ... 44 centers with an emphasis on U.S. patients, ... months and older with a clinical diagnosis of ...
(Date:7/30/2015)... FRANCISCO , July 30, 2015 ... market is expected to reach USD 23.01 million ... View Research, Inc. Growing base of geriatric population, increasing ... infections, and rising level of awareness among target customer ... rendering drivers over the forecast period. According to estimates ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
Cached News: